Clinical trials: Idiopathic Overactive Bladder
Overactive Bladder Syndrome
Treatment of the Overactive Bladder Syndrome: A Delphi Study
Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice. The variability in management between specialists and between centers remains high.
- Trial name
- NCT04300400
- Testing
- Delphi questionnaire
- Where
- Belgium
- Volunteers
- 20 people
- Sponsor
- University Hospital, Ghent
Overactive Bladder, Urinary Incontinence
Programmable Timer in the Bladder Rehabilitation Treatment of OAB
The purpose of this study is to evaluate the effect of bladder rehabilitation in a non-selected group of children with idiopathic overactive bladder and to clarify whether the effect of the treatment can be increased by addition…
- Trial name
- NCT00238680
- Testing
- Bladder rehabilitation, Bladder rehabilitation with programmable timer
- Where
- Denmark
- Volunteers
- 100 people
- Sponsor
- University of Aarhus
Overactive Bladder Syndrome
TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)
Part I of the TaPaS trial forms part of a twofold clinical RCT: Part 1) A prospective RCT comparing the efficacy of transcutaneous tibial nerve stimulation (TTNS) with TTNS sham therapy for children with idiopathic overactive…
- Trial name
- TaPaS (NCT04256876)
- Testing
- TTNS
- Where
- Belgium
- Volunteers
- 6 people
- Sponsor
- University Hospital, Ghent
Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
This study aimed to assess the efficacy and safety of onabotulinumtoxinA (botulinum toxin type A) in patients with idiopathic overactive bladder (OAB) and urinary incontinence who had previously failed to respond to…
- Trial name
- NCT06408051
- Testing
- Injection of onabotulinumtoxinA into the bladder wall
- Where
- 2 sites in Turkey (Türkiye)
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Hisar Intercontinental Hospital
Overactive Bladder (OAB), Transcutaneous Neurostimulation
Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation
The absence of infectious, urological and neurological causes defines the idiopathic character of overactive bladder (OAB). Although a progressive approach starting with behavioural therapy (urotherapy) is recommended…
- Conditions
- Overactive Bladder (OAB), Transcutaneous Neurostimulation, Posterior Tibial Nerve Stimulation
- Trial name
- HAV-O-TENS (NCT07030803)
- Testing
- Oxybutynin, medical device Urostim
- Where
- France
- Volunteers
- 124 people
- Sponsor
- Centre Hospitalier Universitaire, Amiens